Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.31 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | PTGES2 | Q9H7Z7 | 2/20 | 0.30 |
| ▸ | PTGES | O14684 | 1/20 | 0.30 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12647631 | 0.95 | PDK2 (0.38) | PDK2KDM4ENR4A2PGR | |
| SCHEMBL12647527 | 0.94 | L3MBTL1 (0.41) | PDK2KDM4EATML3MBTL1TSPO | |
| SCHEMBL10018641 | 0.94 | PDK2 (0.36) | PDK2KDM4EATML3MBTL1TSPO | |
| SCHEMBL2609877 | 0.92 | PDK2 (0.35) | PDK2KDM4EATML3MBTL1TSPO | |
| SCHEMBL14960778 | 0.92 | KDM4E (0.36) | PDK2KDM4EATML3MBTL1TSPO | |
| SCHEMBL12647531 | 0.92 | PDK2 (0.32) | PDK2HDAC4PGRTDP2 | |
| SCHEMBL2609845 | 0.91 | L3MBTL1 (0.45) | PDK2KDM4EATML3MBTL1TSPO | |
| SCHEMBL2609838 | 0.91 | KDM4E (0.45) | KDM4EATML3MBTL1TSPOHDAC4 | |
| SCHEMBL12647529 | 0.91 | HPGD (0.36) | PDK2KDM4EATML3MBTL1NR3C1 | |
| SCHEMBL17209209 | 0.91 | PDK2 (0.38) | PDK2KDM4EATML3MBTL1TSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9233923-B2 | Organic compounds for organic electronic devices and terminals | DUK SAN NEOLUX CO., LTD. (KR) | 2016-01-12 | — | — | US | disclosed |
| US-9233923-B2 | Organic compounds for organic electronic devices and terminals | DUK SAN NEOLUX CO., LTD. (KR) | 2016-01-12 | — | — | US | disclosed |
| US-20120018717-A1 | ORGANIC ELECTRONIC DEVICE, COMPOUNDS FOR SAME, AND TERMINAL | DUKSAN HIGH METAL CO., LTD. (KR) | 2012-01-26 | — | — | US | disclosed |
| US-20120018717-A1 | ORGANIC ELECTRONIC DEVICE, COMPOUNDS FOR SAME, AND TERMINAL | DUKSAN HIGH METAL CO., LTD. (KR) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120018717-A1 | ORGANIC ELECTRONIC DEVICE, COMPOUNDS FOR SAME, AND TERMINAL | OR10J3, OR51E2, ESR1 | PDK2 3284/4885KDM4E 648/4885ATM 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.